Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Small study explores how IBD patients and doctors choose telemonitoring

NCT ID NCT07155486

Knowledge-focused Sponsor: Franciscus Gasthuis Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study interviewed 10 IBD patients and 6 healthcare professionals to understand how they make shared decisions about using telemonitoring versus standard care. The goal is to improve the decision-making process so patients feel more engaged and informed. The study did not test any treatment or device.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors and patients make better, more informed choices about using telemonitoring for IBD care.
What could go wrong
This is a small, completed interview study with only 17 participants, so findings may not apply to all IBD patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

17 people

The number who actually took part.

Started

Apr 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population comprises adult (≥18 years) IBD patients and IBD healthcare professionals at JBZ and Franciscus who have experienced making a choice about telemonitoring. These hospitals are teaching institutions with a combined patient population of approximately 4000 individuals.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 18 years * Confirmed IBD diagnosis Exclusion Criteria: * Non

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IBD (inflammatory bowel disease) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

inflammatory bowel disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IBD (inflammatory bowel disease) Shared decision making Telemedicine Telemonitoring

Contacts and locations

Locations

  • Franciscus

    Rotterdam, 3045PM, Netherlands

  • Jeroen Bosch Ziekenhuis

    's-Hertogenbosch, 5223GZ, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.